Archaeosome Vaccine Adjuvants Induce Strong Humoral, Cell-Mediated, and Memory Responses: Comparison to Conventional Liposomes and Alum
- 1 January 2000
- journal article
- research article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 68 (1) , 54-63
- https://doi.org/10.1128/iai.68.1.54-63.2000
Abstract
Ether glycerolipids extracted from various archaeobacteria were formulated into liposomes (archaeosomes) possessing strong adjuvant properties. Mice of varying genetic backgrounds, immunized by different parenteral routes with bovine serum albumin (BSA) entrapped in archaeosomes (∼200-nm vesicles), demonstrated markedly enhanced serum anti-BSA antibody titers. These titers were often comparable to those achieved with Freund's adjuvant and considerably more than those with alum or conventional liposomes (phosphatidylcholine-phosphatidylglycerol-cholesterol, 1.8:0.2:1.5 molar ratio). Furthermore, antigen-specific immunoglobulin G1 (IgG1), IgG2a, and IgG2b isotype antibodies were all induced. Association of BSA with the lipid vesicles was required for induction of a strong response, and >80% of the protein was internalized within most archaeosome types, suggesting efficient release of antigen in vivo. Encapsulation of ovalbumin and hen egg lysozyme within archaeosomes showed similar immune responses. Antigen-archaeosome immunizations also induced a strong cell-mediated immune response: antigen-dependent proliferation and substantial production of cytokines gamma interferon (Th1) and interleukin-4 (IL-4) (Th2) by spleen cells in vitro. In contrast, conventional liposomes induced little cell-mediated immunity, whereas alum stimulated only an IL-4 response. In contrast to alum and Freund's adjuvant, archaeosomes composed of Thermoplasma acidophilum lipids evoked a dramatic memory antibody response to the encapsulated protein (at ∼300 days) after only two initial immunizations (days 0 and 14). This correlated with increased antigen-specific cell cycling of CD4+ T cells: increase in synthetic (S) and mitotic (G2/M) and decrease in resting (G1) phases. Thus, archaeosomes may be potent vaccine carriers capable of facilitating strong primary and memory humoral, and cell-mediated immune responses to the entrapped antigen.Keywords
This publication has 52 references indexed in Scilit:
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- T CELL MEMORYAnnual Review of Immunology, 1998
- CD4+ T-cell memory, CD45R subsets and the persistence of antigen—a unifying conceptImmunology Today, 1998
- Engineering liposomes for drug delivery: progress and problemsTrends in Biotechnology, 1995
- Liposomes as Carriers of Peptide Antigens: Induction of Antibodies and Cytotoxic T Lymphocytes to Conjugated and Unconjugated PeptidesImmunological Reviews, 1995
- Stability of pressure-extruded liposomes made from archaeobacterial ether lipidsApplied Microbiology and Biotechnology, 1994
- On the revised structure of the major phospholipid of Halobacterium salinariumBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1993
- Adjuvants: current status, clinical perspectives and future prospectsImmunology Today, 1993
- Specific assays for cytokine production by T cellsJournal of Immunological Methods, 1989
- Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1Nature, 1985